The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...

That hasn't necessarily stopped people, however: A study released in late June 2024 revealed that 29.7% of adults over age 60 still pop a daily aspirin. Here's what to know about the benefits and ...

Up to 15% of older adults may be routinely taking aspirin for primary prevention, and most of them understand the excess ...

Aspire Biopharma enrolls last patient in phase 1 trial of its oral transmucosal fast-acting high-dose aspirin formulation: Estero, Florida Thursday, June 26, 2025, 18:00 Hrs [IST] ...

A new study from researchers at MIT has ignited debate over the effects of AI tools such as ChatGPT on learning and critical thinking. The results of the study suggest that prolonged use of generative ...

The new study analyzed data on 4,252 men and women who participated in the 1999 to 2004 federal survey called NHANES, or the National Health and Nutrition Examination Survey, a yearly checkup of ...

ESTERO, FL AND NEW YORK, NY / ACCESS Newswire / June 24, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery ...

Phase 1 Study Design The Phase 1 clinical trial, which is being conducted in the United States, compares the pharmacokinetic and pharmacodynamic characteristics of normal healthy adult volunteers ...

Press Releases Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation ...